Oxaliplatin improves survival in stage III CRC patients aged 70 years or younger, but not in older patients or those with stage II disease. Patients aged more than 70 years receiving oxaliplatin face ...
The numbers don’t lie: Colorectal cancer (CRC) has been on the rise in younger people in the United States for over two decades. The new analysis found that childhood exposure to a carcinogenic toxin ...
Across frailty levels the incidence of CRC was substantially exceeded by the cumulative incidence of non-CRC death at 10-year follow-up for those with adenoma. HealthDay News — Older adults with ...
These results emphasize the importance of defining patterns of variance in early-onset CRC survival in order to understand the impact of community health behaviors on early-onset CRC outcomes. Study ...
On the left, workflow of the Identification of high-confidence risk genes for CRC via iRIGS. On the right (top), Functional characterization of predicted risk genes. On the right (bottom), Graphical ...
A proof-of-concept formative trial evaluating the interest of multiple connected devices for the early detection of hand-foot skin reactions in patients treated with regorafenib therapy (FACET).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results